Skip to main content
PTSD & Trauma

Navigated TMS Added to Residential Therapy for Combat-Related PTSD

Grade A-Randomized, sham-controlled trial2026

What did this study find?

In this blinded trial, 119 military personnel and veterans with combat-related PTSD received 30 days of intensive residential therapy plus either navigated TMS or sham. Both groups improved. At the end of treatment, the active TMS group showed greater symptom relief than sham on both PTSD measures. TMS is a clinical procedure distinct from consumer PEMF devices.

What are the details of this record?

Full citation
Fox PT, Salinas FS, Roache JD, et al. Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(4):e265110. doi:10.1001/jamanetworkopen.2026.5110.
Journal
JAMA Network Open
Authors
Fox PT, Salinas FS, Roache JD, Quinones M, Vaughan PW, Franklin C, Straud CL, Price L, Unzueta-Hernandez M, Woolsey MK, Chavez AM, Hoselton DA, Brundige AR, Litz BT, Young-McCaughan S, Keane TM, Peterson AL; Consortium to Alleviate PTSD
Study design
Randomized, sham-controlled trial
Sample size and population
119 active-duty military personnel and veterans (60 active TMS, 59 sham)
Evidence grade
Grade A- on the BioReg grading scale
Reported findings
Patients, staff and assessors were blinded. Navigated TMS added to 30 days of residential therapy produced greater PTSD symptom relief than sham at end of treatment (PCL-5 difference -5.94, 95% CI -11.77 to -0.10; CAPS-5 difference -6.03, 95% CI -10.84 to -1.22). Both arms improved from baseline. Transcranial magnetic stimulation is a clinical procedure; findings do not transfer directly to PEMF devices.
Funding and conflicts of interest
The paper's conflict of interest disclosures read, in part: "Dr Fox reported receiving grants from the US Department of Defense (DoD) Consortium to Alleviate PTSD during the conduct of the study, having a patent for navigated transcranial magnetic stimulation for posttraumatic stress disorder (PTSD) treatment licensed to Cerebral Magnetics, and having equity in Cerebral Magnetics. Prof Salinas reported receiving grants from the DoD and US Department of Veterans Affairs (VA) during the conduct of the study; receiving personal fees from Cerebral Magnetics outside the submitted work; and having a patent for Fox PT system, apparatus, and methods for image-guided, robotically delivered transcranial magnetic stimulation treatment."

A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.